Issue 79 | February 2019

In this issue: : knock on effects of the Valsartan recall, the future of AI in healthcare, the history of the Petri dish, and much more.

Issue 78 | January 2019

In this issue: : A new class of cancer combo treatments, antidepressants in the environment, microbiome-based drug development, and more.

Issue 77 | December 2018

In this issue: China’s growing pharmaceutical market, antimicrobial resistance, the rise of tech giants in healthcare, and more.

Issue 76 | November 2018

In this issue: HPV vaccine programmes, dominantly inherited Alzheimer’s disease, a unique brain ‘fingerprint’ and more.

Special Issue | October 2018

In this issue: Manufacturing personalised medicine, the economics of CAR-T treatments, AI in drug combination therapy and more.

Issue 75 | October 2018

In this issue: Making manufacturing work in gene and cell therapies, AI generated compounds, clinical trial transparency in the Americas, and more.

Issue 74 | September 2018

In this issue: Boosting trust in big pharma, the highs and lows of the world’s most expensive drug, gene therapy, and more.

Issue 73 | August 2018

In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research, and more.

Issue 72 | July 2018

In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and more.

Issue 71 | June 2018

In this issue: A surge of M&A activity in the biotech space, the history of drug development for mumps, a profile of the Swiss pharmaceutical market, using digital tech to unlock billions in savings for pharma companies, and more.

Issue 70 | May 2018

In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre for Drug Research and Development, and more.

Issue 69 | April 2018

In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs, and more.

Issue 68 | March 2018

In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells, a look at drug pricing policies around the world, and more.

Issue 67 | February 2018

In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence in pharma research, and more.

Issue 66 | January 2018

In this issue: Breaking cancer’s drug addiction, the NHS’ decision to switch from biologics to biosimilars, Elsevier’s common model for data sharing, a generic antiretroviral for HIV/AIDS, the opioid addiction crisis in the US, and more.

Special Issue | Yearbook 2017

In this issue: We round up the biggest pharma developments and stories from around the globe in 2017, consider the impact Brexit could have on IDMP preparations, take a closer look at the outlook for the pharmaceutical industry in 2018, and more.

Issue 65 | December 2017

In this issue: Calls for closer ties between the NHS and pharma, Norway’s unique prescription database, a new way to reduce the risk of heart attacks, MDMA’s potential to treat PTSD, a curative compound derived from red sage, and more.

Issue 64 | November 2017

In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial R&D, helping nanomedicines reach their target, radioactive isotopes battling cancer, and more.

Issue 63 | October 2017

In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the current state of drug development in osteoporosis, and more.

Issue 62 | September 2017

In this issue: A new tool to encourage links between industry and academia, blockchain’s applications for pharma, using Zika to attack brain tumour cells, treating MS with nanotechnology, the benefits of publicly funded cancer trials, and more.

Issue 61 | August 2017

In this issue: The UK’s healthcare spending problem, PhRMA’s new R&D spending requirements, undermining supply chain security by importing foreign drugs, milestone cystic fibrosis trials, a personalised treatment approach for panic disorder, and more.

Issue 60 | July 2017

In this issue: Solving US drug pricing issues by importing cheaper Canadian drugs, underexplored fields in immuno-oncology, a new temperature-resistant rabies and yellow fever vaccine, the increasingly popularity of adaptive clinical trials, and more.

Issue 59 | June 2017

In this issue: Challenging the link between innovation and US drug pricing, the impact of Brexit on life sciences companies, a new study on the effects of cognitive-enhancing drugs, using crowdfunding to unlock cancer therapies, and more.

Issue 58 | May 2017

In this issue: Promising Alzheimer’s drugs in development, potential applications for the hormone kisspeptin, the cost of failed drug candidates, a new app matching patients to clinical trials, pharma packaging trends, and more.

Issue 57 | April 2017

In this issue: Japan’s pharma industry looks abroad, Trump’s plans for US drug manufacturing, unlocking regenerative medicine, the medical benefits of turmeric, the dangers posed by first-in-human drug trials, and more.

Issue 56 | March 2017

In this issue: Clinical research in the UK, fighting diabetes with peptides, balancing speed and safety when reviewing new drugs, the potential of shark antibodies to treat Alzheimer’s, Elsevier’s new project to boost innovation, and more.

Issue 55 | February 2017

In this issue: India’s new drug pricing policy, bringing transparency to pharma industry payments, a UK innovation centre enabling new means of drug discovery, how artificial intelligence is being used in drug development, and more.

Issue 54 | January 2017

In this issue: Senator Bernie Sanders continues to rail against the pharma industry, why companies pay to prolong patents, a new genomic array helping fight disease in Africa, treating mononucleosis, a new era for ibuprofen, and more.

Issue 53 | December 2016

In this issue: Pfizer’s acquisition of AstraZeneca’s antibiotics unit, new ideas to tackle antimicrobial resistance, vaccines to look out for in 2017, targeting Tourette syndrome, using ketamine to treat depression, and more.

Issue 52| November 2016

In this issue:A report calls for Oxford and Cambridge to work together in the biopharma sector, IBM’s new lab-on-a-chip technology, whether harnessing telomerase could trick the ageing process, how BERG is using AI to develop drugs, and more.

Issue 51 | October 2016

In this issue:Efficiency in Australia’s pharma industry, India’s move to biosimilars, painkillers that don’t rely on opioids, NHS England’s funding of HIV drug PrEP, whether stem cell transplants can be used to treat MS, and more.

Issue 50 | September 2016

In this issue: Maximising investment by cancer megafunds, positive clinical trials for an antibody to treat lupus, how copper can be used to tackle obesity, whether day and night should influence our drug regimes, a device to soak up excess drugs and more.

Issue 49 | August 2016

In this issue: Improving treatment for refugees, making global drug price regulation work, a new approach to AMR, tackling depression with psilocybin, combating counterfeit Viagra, innovations in temperature controlled packaging and more.

Issue 48 | July 2016

In this issue: Nurturing an African pharma boom, the challenges of designing biodegradable drugs, the UK’s R&D tax credit scheme, advances in prostate cancer treatment, treating heroin addiction, best practice for anonymising clinical trial data and more.

Issue 47 | June 2016

In this issue: The breast cancer drug pipeline, getting biosimilars to market, the debate about animal research, olive leaf extract on trial, text mining in the biotech sector, outsourcing clinical trials in emerging markets and more.

Issue 46 | May 2016

In this issue: Getting a grip on the Zika virus, mining for medicines, Obama’s cancer moonshot, learning from Bial’s French trial disaster, digital innovation in pharmaceutical packaging and more.

Issue 45 | April 2016

In this issue:Israel’s pharma market, what Brexit would mean for clinical research in the UK, developments in obstetrics, the trouble with inhalable insulin, the FDA’s new support for innovation in manufacturing, plant-based vaccine manufacturing and more.

Issue 44 | March 2016

In this issue: Clinical trials in Russia, how understanding the microbiome could help with drug delivery, making the most of data analytics, the potential of wearable trackers in clinical trial data collection, the pharma industry’s role in fighting climate change and more.

Issue 43 | February 2016

In this issue: A look inside China’s pharmaceutical market, GSK’s pipeline to 2020, tackling the world’s most pressing clinical needs, new digital tools for clinical trials, a new approach to predicting side effects and more.

Issue 42 | January 2016

In this issue: Bridging the GP – big pharma divide, the year ahead in regulation, world-changing research into parasitic diseases, the first 3D printing method for adult stem cells, the ethics of marketing pharmaceuticals online, and more.

Issue 41 | December 2015

In this issue: regulation updates for EU-FMD and IDMP, why flibanserin remains controversial, why farm dust could be the key to preventing asthma, new efforts to reduce placebo use in clinical trials, and more.

Issue 40 | November 2015

In this issue: The industry’s quest for abuse-deterrent painkillers, progress of the US Drug Quality and Security Act, innovations in asthma treatment, the search for alternatives to antibiotics, how the UK’s biosciences sector can attract new talent, and more.

Issue 39 | October 2015

In this issue: How the industry can prepare for Britain’s EU referendum, London’s proposed £10bn drug development ‘megafund’, why antibiotics innovation has stalled despite the growing AMR threat, new malaria research that could lead to a $1 cure, the potential of statins for cancer treatment, and more.

Issue 38 | September 2015

In this issue: South Africa’s long road to domestic manufacturing, the 21st Century Cures Act divides opinion in the US, closing the talent gap in contract research, the growing market for unlicensed drugs, and more.

Issue 37 | August 2015

In this issue: New findings on fake medicines, progress in predicting cancer, the rocky road ahead for biosimilars developers, a new wave of treatments for hearing loss, trends in packaging and more.

Issue 36 | July 2015

In this issue: A new gene therapy for lung cancer, a new approach to hepatitis B vaccines, tackling obesity with bioengineered bacteria, what Apple’s ResearchKit brings to clinical trials, big data solutions to pharma’s problems, European marketing self-regulation under fire, and more.

Issue 35 | May 2015

In this issue: How pharmacogenomics is paving the way for personalised drug plans, new ideas for flu vaccine development, fighting antimicrobial resistance on all fronts, why a regulatory re-think is needed to unlock the potential of regenerative medicine and more.

Issue 34 | March 2015

In this issue: Unlocking unknown benefits of existing drugs, a new approach to stopping cancer spread, competition and opportunities in the HIV drugs market, building up business in Japan, striking the right balance with child-resistant drug packaging and more.

Issue 33 | January 2015

In this issue: Building on the success of dropping child cancer death rates in the UK, upcoming changes for 2015, the effects of mergers on innovation, rethinking the role of the placebo, neuropathic pain treatments in the pipeline, and more

Issue 32 | December 2014

In this issue: New combinations of existing cancer treatments show promising results, complying with new EU-FMD safety features, increasing time to market with new technologies, lymphoma treatments in the pipeline, tackling AMR with nanotechnology and more.

Issue 31 | October 2014

The clinical trials special issue: the economics of large-scale trials, new treatments for Type 2 Diabetes and obesity, the benefits of adaptive licensing for orphan drugs, data and trial management software and more.

Issue 30 | August 2014

In this issue: A new approach to Alzheimer’s clinical trials, India’s ambitions to jump from generics manufacturer to drug innovator, integrating real-life data into drug development, a new era for PAH treatment in the UK, self-expiring pharma packaging and more.

Issue 29 | June 2014

In this issue: Ireland’s pharma market after the patent cliff, changes in life science investment, the drug pricing debate, statins in the spotlight, the medical potential of honey and more

Issue 28 | April 2014

In this issue: A functional cure for HIV, the new clinical data sharing principles, what the industry has learned from the influenza A pandemic five years ago, pain-free injections with microneedles and more

Issue 27 | February 2014

In this issue: Boosting clinical trial participation, the potential of bioprinting in regenerative medicine, progress in type 1 diabetes vaccines, the US military’s plant-based vaccine production project, software that speeds up tumour tissue analysis, controlling malaria and dengue fever outbreaks with open-source modelling, and more.

Issue 26 | December 2013

In this issue: The future of bioelectronic medicine, the winners of the Pharma Technology Focus Awards 2013, what the US Supreme Court’s ruling on DNA patenting means for future research, the ethics of advertising prescription drugs directly to patients, why elemental impurity analysis needs to be modernised, a look at the influenza vaccine market, the controversial decision-making process for cancer drug approvals in the UK, and more

Issue 25 | October 2013

In this issue: How personalised medicine could revolutionise future medical care, recent breakthroughs in the battle against Malaria, how changes to GMP guidelines across Europe will affect CMOs and their customers, overcoming the challenges of managing cold chains in regions with weak infrastructures, a look at new anti-counterfeit regulations for manufacturing and distribution, and more

Issue 24 | August 2013

In this issue: Could nano-robots change the game for targeted drug delivery? Plus: The cancer-killing avian virus, challenges in implementing the EC’s Falsified Medicines Directive, Type 2 diabetes market insight, the placebo trend in the UK, the health implications of antibiotics in the food chain, new developments in drug delivery devices, and more

Issue 23 | June 2013

In this issue: New opportunities for the generics market, the potential of plant molecular farming, a new generation of transdermal patches, how a new nerve targeting drug delivery system could revolutionise the treatment of intractable pain, the challenges of developing combination drugs, cold chain technology, and more

Issue 22 | April 2013

In this issue: The EU’s parallel drug trade dilemma, the controversy surrounding clinical data disclosure, a new subcutaneous drug delivery platform, the future of analgesic drug development, building an effective cold chain, Mexico’s rise in the pharma market, growth opportunities for biopharma in Latin America, and more

Issue 21 | March 2013

In this issue: New hope for preventative HIV vaccination, crowdfunding clinical research, effective cancer treatment with antibody-drug conjugates, the role of naïve t-cells in cancer and HIV treatment, continuous manufacturing, new inhalation technology, and more.

Issue 20 | December 2012

In Short Supply: The role of the supply chain in tackling drug shortages | Plus: Getting emergency healthcare into Syria, cloud-based supply chain management, preventing medical cargo theft, the push for continuous temperature monitoring, and more

Issue 19 | November 2012

Small Players, Big Potential: Why small biotech companies take the innovative edge in new drug development | Plus: A push for Alzheimer’s research, the search for a more effective TB treatment, new schizophrenia discoveries, and more

Issue 18 | October 2012

Fighting Fakes: From packaging technology to new legislation, industry and regulators are battling on all fronts against the spread of counterfeit medicines.

Issue 17 | September 2012

Output vs. Quality: Are increasingly stringent regulations on manufacturing and ingredients the cause for the growing problem of drug shortages?

Issue 16 | August 2012

Cutting the Paper Trail: Clinical trials need better streamlined technology and industry-wide standards to become more efficient

Issue 15 | July 2012

Programmable, self-propelled and powerful: How nano-devices could open up the door to a new era of highly targeted drug delivery.

Issue 14 | June 2012

Clouds of change : How advanced computing technology will help Big Pharma to manage and streamline the growing amounts of ever more complex clinical data.

Issue 13 | May 2012

In the pipeline: From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new frontiers.

Issue 12 | April 2012

In this issue: Essential protection – pharmaceuticals place high demands on packaging, giving rise to ever more advanced packaging technologies to ensure the safety and usability of medicines.

Issue 11 | March 2012

Issue theme: Manufacturing and ingredients – We look at technological advances in the field of pharmaceutical manufacturing and APIs and explore some of the challenges faced by companies operating in the sector.

Issue 10 | February 2012

Issue theme: Trial & Success – We explore the best strategies and the latest technology that can hep to make clinical trials quicker, safer and more cost-efficient

Issue 9 | January 2012

Issue theme: Advanced Delivery – From nanoscale targeting to controlled release breakthroughs, rapidly evolving delivery methods are making medicines more effective than ever

Issue 8 | December 2011

Issue Theme: Essential Networks – How the industry can secure supply chains while improving efficiencies in logistics

Issue 7 | Novermber 2011

Issue Theme: Finding new cures – Market shifts and emerging technologies are pushing drug development into a new era

Issue 6 | October 2011

Issue Theme: What’s on the label – Advanced packaging and labelling systems are essential in making medicines safer

Issue 5 | September 2011

Issue Theme: Life-saving precision: We look at trends in pharmaceutical manufacturing

Issue 4 | August 2011

Issue Theme: Combating counterfeits – how the industry can protect products, the supply chain and patients from the black market trade

Issue 3 | July 2011

Issue Theme: Better medicine – from needle free to nanotechnology, new drug delivery systems are set to revolutionise medical treatment

Issue 2 | June 2011

Issue Theme: The road to market – how pharma companies can meet the challenges of today’s increasingly complex supply chains

Issue 1 | May 2011Issue Theme : Drug discovery and development